US FDA Averted Drug Shortages With Production Data Manufacturers Shared Last Year
Executive Summary
Firms showed agency confidential production plan details upon request so it could help guide them through a challenging mix of quality-related supply challenges and respiratory disease-related demand challenges, according to 2022 drug shortage report.